Modulation of Hypoxia-Induced Neovascularization by JSM6427, an Integrin α5β 1 Inhibiting Molecule

REFERENCES

• Mechoulam H, Pierce E A. Retinopathy of prematurity: molecular pathology and therapeutic strategies. Am J Pharmacogenomics 2003; 3: 261–277
   PubMedGoogle Scholar
• Pierce E A, Foley E D, Smith L E. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol. 1996; 114: 1219–1228
   PubMedGoogle Scholar
• Reynolds J D. The management of retinopathy of prematurity. Paediatr Drugs. 2001; 3: 263–272
   PubMed Web of Science ®Google Scholar
• Smith L E, Wesolowski E, McLellan A, Kostyk S K, D'Amato R, Sullivan R, D'Amore P A. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994; 35: 101–111
   PubMed Web of Science ®Google Scholar
• Elner S G, Elner V M. The integrin superfamily and the eye. Invest Ophthalmol Vis Sci. 1996; 37: 696–701
   PubMed Web of Science ®Google Scholar
• Hynes R O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992; 69: 11–25
   PubMed Web of Science ®Google Scholar
• Yang J T, Rayburn H, Hynes R O. Embryonic mesodermal defects in alpha 5 integrin-deficient mice. Development. 1993; 119: 1093–1105
   PubMed Web of Science ®Google Scholar
• Goh K L, Yang J T, Hynes R O. Mesodermal defects and cranial neural crest apoptosis in alpha5 integrin-null embryos. Development. 1997; 124: 4309–4319
   PubMed Web of Science ®Google Scholar
• Francis S E, Goh K L, Hodivala-Dilke K, Bader B L, Stark M, Davidson D, Hynes R O. Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler Thromb Vasc Biol. 2002; 22: 927–933
   PubMed Web of Science ®Google Scholar
• George E L, Georges-Labouesse E N, Patel-King R S, Rayburn H, Hynes R O. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development. 1993; 119: 1079–1091
   PubMed Web of Science ®Google Scholar
• Kim S, Bell K, Mousa S A, Varner J A. Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am J Pathol. 2000; 156: 1345–1362
   PubMed Web of Science ®Google Scholar
• Parsons-Wingerter P, Kasman I M, Norberg S, et al. Uniform overexpression and rapid accessibility of alpha5beta1 integrin on blood vessels in tumors. Am J Pathol. 2005; 167: 193–211
   PubMed Web of Science ®Google Scholar
• Magnussen A, Kasman I M, Norberg S, Baluk P, Murray R, McDonald D M. Rapid access of antibodies to alpha5beta1 integrin overexpressed on the luminal surface of tumor blood vessels. Cancer Res. 2005; 65: 2712–2721
   PubMedGoogle Scholar
• Chavakis T, Cines D B, Rhee J S, et al. Regulation of neovascularization by human neutrophil peptides.alpha-defensins): a link between inflammation and angiogenesis. FASEB J. 2004; 18: 1306–1308
   PubMed Web of Science ®Google Scholar
• Orecchia A, Lacal P M, Schietroma C, Morea V, Zambruno G, Failla C M. Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the alpha 5 beta 1 integrin. J Cell Sci. 2003; 116: 3479–3489
   PubMed Web of Science ®Google Scholar
• Umeda N, Kachi S, Akiyama H, Zahn G, Vossmeyer D, Stragies R, Campochiaro P. Suppression and regression of choroidal neovascularization by systemic administration of an alpha5beta1 integrin antagonist. Mol Pharmacol. 2006; 69: 1820–1828
   PubMed Web of Science ®Google Scholar
• Korff T, Augustin H G. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J Cell Biol. 1998; 143: 1341–1352
   PubMed Web of Science ®Google Scholar
• Korff T, Augustin H G. Tensional forces in fibrillar extracellular matrices control directional capillary sprouting. J Cell Sci. 1999; 112: 3249–3258, (Pt 19)
   PubMed Web of Science ®Google Scholar
• Stragies R, Osterkamp F, Zischinsky G, Vossmeyer D, Kalkhof H, Reimer U, Zahn G. Design and synthesis of a new class of selective Integrin α 5β1 antagonists. J Med Chem 2007; 50: 3786–3794, (Epub 06 Jul 2007)
   PubMedGoogle Scholar
• Browning J, Wylie C K, Gole G. Quantification of oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1997; 38: 1168–1174
   PubMedGoogle Scholar
• Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med. 1995; 1: 1024–1028
   PubMed Web of Science ®Google Scholar
• Pierce E A, Avery R L, Foley E D, Aiello L P, Smith L E. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A. 1995; 92: 905–909
   PubMed Web of Science ®Google Scholar
• Aiello L P, Pierce E A, Foley E D, et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor. (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A. 1995; 92: 10457–10461
   PubMed Web of Science ®Google Scholar
• Aiello L P, Avery R L, Arrigg P G, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994; 331: 1480–1487
   PubMed Web of Science ®Google Scholar
• Miller J W, Adamis A P, Shima D T, et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol. 1994; 145: 574–584
   PubMed Web of Science ®Google Scholar
• Ozaki H, Seo M S, Ozaki K, et al. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol. 2000; 156: 697–707
   PubMed Web of Science ®Google Scholar
• Ramakrishnan V. F200, a potent FAB against alpha5beta1 integrin as antiangiogenic therapy for AMD. Paper presented at the Conference Ocular Angiogenesis, Cambridge, MA, 2004
   Google Scholar
• Enenstein J, Waleh N S, Kramer R H. Basic FGF and TGF-beta differentially modulate integrin expression of human microvascular endothelial cells. Exp Cell Res. 1992; 203: 499–503
   PubMed Web of Science ®Google Scholar
• Collo G, Pepper M S. Endothelial cell integrin alpha5beta1 expression is modulated by cytokines and during migration in vitro. J Cell Sci 1999; 112: 569–578, (Pt 4)
   PubMed Web of Science ®Google Scholar
• Gardiner T A, Gibson D S, de Gooyer T E, de la Cruz V F, McDonald D M, Stitt A W. Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. Am J Pathol. 2005; 166: 637–644
   PubMed Web of Science ®Google Scholar
• Kim S, Harris M, Varner J A. Regulation of integrin alpha vbeta 3-mediated endothelial cell migration and angiogenesis by integrin alpha5beta1 and protein kinase A. J Biol Chem. 2000; 275: 33920–33928
   PubMed Web of Science ®Google Scholar
• Economopoulou M, Bdeir K, Cines D B, et al. Inhibition of pathologic retinal neovascularization by alpha-defensins. Blood. 2005; 106: 3831–3838
   PubMed Web of Science ®Google Scholar
• Bader B L, Rayburn H, Crowley D, Hynes R O. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins. Cell. 1998; 95: 507–519
   PubMed Web of Science ®Google Scholar
• Reynolds L E, Wyder L, Lively J C, et al. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat Med. 2002; 8: 27–34
   PubMed Web of Science ®Google Scholar
• Hynes R O. A reevaluation of integrins as regulators of angiogenesis. Nat Med. 2002; 8: 918–921
   PubMed Web of Science ®Google Scholar
• Hammes H P, Brownlee M, Jonczyk A, Sutter A, Preissner K T. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat Med. 1996; 2: 529–533
   PubMed Web of Science ®Google Scholar
• Drake C J, Davis L A, Hungerford J E, Little C D. Perturbation of beta 1 integrin-mediated adhesions results in altered somite cell shape and behavior. Dev Biol. 1992; 149: 327–338
   PubMed Web of Science ®Google Scholar
• Guo M, Kim L T, Akiyama S K, Gralnick H R, Yamada K M, Grinnell F. Altered processing of integrin receptors during keratinocyte activation. Exp Cell Res. 1991; 195: 315–322
   PubMed Web of Science ®Google Scholar
• Schreiner C L, Fisher M, Bauer J, Juliano R L. Defective vasculature in fibronectin-receptor-deficient CHO cell tumors in nude mice. Int J Cancer. 1993; 55: 436–441
   PubMedGoogle Scholar
• Stitt A W, Graham D, Gardiner T A. Ocular wounding prevents pre-retinal neovascularization and upregulates PEDF expression in the inner retina. Mol Vis. 2004; 10: 432–438
   PubMedGoogle Scholar
• Unsoeld A S, Junker B, Mazitschek R, Martin G, Hansen L L, Giannis A, Agostini H T. Local injection of receptor tyrosine kinase inhibitor MAE 87 reduces retinal neovascularization in mice. Mol Vis. 2004; 10: 468–475
   PubMed Web of Science ®Google Scholar